Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy

被引：47

作者：

Figueroa-Espada, Christian G. ^{[1
]}

Hofbauer, Samuel ^{[1
]}

Mitchell, Michael J. ^{[1
,3
,4
,5
,6
]}

Riley, Rachel S. ^{[1
,2
]}

机构：

[1] Univ Penn, Dept Bioengn, 210 South 33rd St, Philadelphia, PA 19104 USA

[2] Rowan Univ, Dept Biomed Engn, 201 Mullica Hill Rd, Glassboro, NJ 08028 USA

[3] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[4] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA

[5] Univ Penn, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA

[6] Univ Penn, Inst Regenerat Med, Perelman Sch Med, Philadelphia, PA 19104 USA

来源：

ADVANCED DRUG DELIVERY REVIEWS | 2020年 / 160卷

基金：

美国国家卫生研究院; 美国国家科学基金会;

关键词：

Placenta; Drug delivery technologies; Nanoparticle; Pregnancy; Active targeting; Pre-eclampsia; IN-VITRO; GOLD NANOPARTICLES; CATIONIC LIPIDS; P-GLYCOPROTEIN; GENE-TRANSFER; QUANTUM DOTS; PLASMID DNA; TRANSPORT; MODEL; MICE;

D O I：

10.1016/j.addr.2020.09.006

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A major challenge to treating diseases during pregnancy is that small molecule therapeutics are transported through the placenta and incur toxicities to the developing fetus. The placenta is responsible for providing nutrients, removing waste, and protecting the fetus from toxic substances. Thus, the placenta acts as a biological barrier between the mother and fetus that can be exploited for drug delivery. Nanoparticle technologies provide the opportunity for safe drug delivery during pregnancy by controlling how therapeutics interact with the placenta. In this Review, we present nanoparticle drug delivery technologies specifically designed to exploit the placenta as a biological barrier to treat maternal, placental, or fetal diseases exclusively, while minimizing off-target toxicities. Further, we discuss opportunities, challenges, and future directions for implementing drug delivery technologies during pregnancy. (C) 2020 Elsevier B.V. All rights reserved.

引用

页码：244 / 261

页数：18

共 151 条

[1] Development of Non-Viral, Trophoblast-Specific Gene Delivery for Placental Therapy [J].

Abd Ellah, Noura ;

Taylor, Leeanne ;

Troja, Weston ;

Owens, Kathryn ;

Ayres, Neil ;

Pauletti, Giovanni ;

Jones, Helen .

PLOS ONE, 2015, 10 (10)

[2] Gold nanoparticle distribution in advanced in vitro and ex vivo human placental barrier models [J].

Aengenheister, Leonie ;

Dietrich, Doerthe ;

Sadeghpour, Amin ;

Manser, Pius ;

Diener, Liliane ;

Wichser, Adrian ;

Karst, Uwe ;

Wick, Peter ;

Buerki-Thurnherr, Tina .

JOURNAL OF NANOBIOTECHNOLOGY, 2018, 16

[3] An advanced human in vitro co-culture model for translocation studies across the placental barrier [J].

Aengenheister, Leonie ;

Keevend, Kerda ;

Muoth, Carina ;

Schonenberger, Rene ;

Diener, Liliane ;

Wick, Peter ;

Buerki-Thurnherr, Tina .

SCIENTIFIC REPORTS, 2018, 8

[4] Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial [J].

Ahmed, A. ;

Williams, D. J. ;

Cheed, V. ;

Middleton, L. J. ;

Ahmad, S. ;

Wang, K. ;

Vince, A. T. ;

Hewett, P. ;

Spencer, K. ;

Khan, K. S. ;

Daniels, J. P. ;

Barber, Katherine ;

Kilby, Mark ;

Knox, Ellen ;

Sellman, Tara ;

Trinham, Paula ;

Tuffnell, Derek ;

Jones, Vicky ;

Syson, Jennifer ;

Shah, Neil ;

Deeks, Laurie ;

Carter, Wendy ;

Dorman, Ed ;

Thomas, Susannah ;

Harrington, Deborah ;

Higgins, Nicola ;

Wilmott-Powell, Mirriam ;

Simpson, Nigel ;

Dolby, Vivian ;

Bricker, Leanne ;

Walkinshaw, Steve ;

Houghton, Gillian ;

Longworth, Heather ;

Williamson, Catherine ;

Dhanjal, Mandish ;

Noori, Muna ;

Machirori, Mavis ;

Howard, Richard ;

Murray, Rebecca ;

Weist, Sarah ;

Denison, Fiona ;

Crawford, Isobel ;

Robson, Stephen ;

Allan, Carly ;

Myers, Jenny ;

Bernatavicius, Giovanna ;

Moorhead, Lynsey ;

Chappell, Lucy ;

Nelson-Piercy, Catherine ;

Williams, David .

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (04) :478-488

[5] Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model [J].

Ahn, Nicholas J. ;

Stratigis, John D. ;

Coons, Barbara E. ;

Flake, Alan W. ;

Nah-Cederquist, Hyun-Duck ;

Peranteau, William H. .

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (140)

[6] Placental control of drug delivery [J].

Al-Enazy, Sanaalarab ;

Ali, Shariq ;

Albekairi, Norah ;

El-Tawil, Marwa ;

Rytting, Erik .

ADVANCED DRUG DELIVERY REVIEWS, 2017, 116 :63-72

[7] In utero gene editing for monogenic lung disease [J].

Alapati, Deepthi ;

Zacharias, William J. ;

Hartman, Heather A. ;

Rossidis, Avery C. ;

Stratigis, John D. ;

Ahn, Nicholas J. ;

Coons, Barbara ;

Zhou, Su ;

Li, Hiaying ;

Singh, Kshitiz ;

Katzen, Jeremy ;

Tomer, Yaniv ;

Chadwick, Alexandra C. ;

Musunuru, Kiran ;

Beers, Michael F. ;

Morrisey, Edward E. ;

Peranteau, William H. .

SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (488)

[8] Qualitative and quantitative analysis of the uptake of lipoplexes by villous placenta explants [J].

Alhareth, Khair ;

Valero, Lucie ;

Mohamed, Khaled Elhady ;

Fliedel, Louise ;

Roques, Caroline ;

Gil, Sophie ;

Mignet, Nathalie ;

Fournier, Thierry ;

Andrieux, Karine .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 567

[9] Exosome Encased Spherical Nucleic Acid Gold Nanoparticle Conjugates as Potent MicroRNA Regulation Agents [J].

Alhasan, Ali H. ;

Patel, Pinal C. ;

Choi, Chung Hang J. ;

Mirkin, Chad A. .

SMALL, 2014, 10 (01) :186-192

[10] Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model [J].

Ali, Hazem ;

Kalashnikova, Irina ;

White, Mark Andrew ;

Sherman, Michael ;

Rytting, Erik .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 454 (01) :149-157

← 1 2 3 4 5 6 7 8 9 10 →